C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/09/2004	US20040249146 Nucleic acid compositions conferring altered visual phenotypes
12/09/2004	US20040249145 Using carcinoembryonic antigen expression as diagnostic and prognostic indicator of cell proliferative disorders
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249142 Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof
12/09/2004	US20040249141 Tie ligand homologues
12/09/2004	US20040249140 Transcription factors that regulate normal and malignant cell growth
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249134 Factor viii c2 domain variants
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249130 Aptamer-toxin molecules and methods for using same
12/09/2004	US20040249128 Disease detection polypeptides diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, developmental and neurological disorders
12/09/2004	US20040249127 Intracellular signaling molecules
12/09/2004	US20040249126 Chimeric antigen-specific t cell-activating polypeptides
12/09/2004	US20040249124 Viral protein for use in generation of immunogllobulins to prevent lymphadenopathy associated viral infections; immunotherapy; viricides
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040249122 Cationic, amphipathic beta-sheet peptides and uses thereof
12/09/2004	US20040249121 Providing protected linear peptide, reacting protected peptide with acidic composition to produce semi-protected linear peptide with orthogonal protecting group on thiol-containing residues, purify peptide, treat with oxidizing agent, recover cyclic peptide such as octreotide, calcitonin, oxytocin
12/09/2004	US20040248838 Human and mouse choline transporter cDNA
12/09/2004	US20040248836 Administering activator of formin homologue overexpression in spleen; adjusting gene expression
12/09/2004	US20040248830 Agents that regulate apoptosis
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248810 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
12/09/2004	US20040248807 synthetic peptide that corresponds in amino acid sequence to the carboxyl terminal 18 amino acids in the gamma ' chain of fibrinogen
12/09/2004	US20040248805 Vascular endothelial growth factor fusion constructs and uses thereof
12/09/2004	US20040248803 inhibiting Wnt mediated signaling, by inhibiting the palmitoylation of Wnt; purified in the presence of a detergent to maintain solubility; maintenance and growth of stem cells, tissue regeneration
12/09/2004	US20040248800 Crystals and structures of epidermal growth factor receptor kinase domain
12/09/2004	US20040248799 Compositions and methods for treating cancer and hyperproliferative disorders
12/09/2004	US20040248795 unlike calpastatin, the peptides of the invention do not target an active cysteine of calpain; protecting neurons against ultraviolet radiation induced cell death
12/09/2004	US20040248791 Insect g protein-coupled receptor genes and uses thereof
12/09/2004	US20040248790 eating regulator, a sleep regulator,.an arousal regulator, a pain regulator, a stress response regulator, a spontaneous behavior regulator or an emotional behavior regulator
12/09/2004	US20040248789 peptides/fusion inhibitors;
12/09/2004	US20040248787 fusion protein comprising a PTD (protein transduction domain) and an MITF (microphthalmia-associated transcripution factor) variant as an active ingredient with a His tag
12/09/2004	US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/09/2004	US20040248785 mutant factor VIII has procoagulant activity; increased half-life; substituted amino acid(s) in the A2 domain
12/09/2004	US20040248782 Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders
12/09/2004	US20040248780 GSSP-2, GSSP-2 cDNAs and GSSP-2 polypeptides; recombinant vector; host cell
12/09/2004	US20040248778 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides
12/09/2004	US20040248776 Intermediates and methods for making heptapeptide oxytocin analogues
12/09/2004	US20040248766 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders
12/09/2004	US20040248303 Inducible promoter
12/09/2004	US20040248300 Plasmid construct for use in transfer and expression of heterologous gene sequences for use in treatment of nervous system disorders in mammals
12/09/2004	US20040248298 Methods for purification of bacterial cells and components
12/09/2004	US20040248295 Culturing cell populations which are weakly positive or negative for hematopoietic stem cells lineage marker gene expression in mixture comprising colony stimulating factors and isolating amplified hematopoietic cells
12/09/2004	US20040248279 Sporulation defective transgenic bacillus for use as bioreactors for generation of proteins useful in foodstuffs, drugs, cosmetics, detergents and fiber treatments
12/09/2004	US20040248261 Feline IL-12 single chain proteins and nucleic acid molecules
12/09/2004	US20040248260 IL-13 mutein proteins, antibodies, compositions, methods and uses
12/09/2004	US20040248259 VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor
12/09/2004	US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation
12/09/2004	US20040248256 Secreted proteins and polynucleotides encoding them
12/09/2004	US20040248254 ACPL DNA and polypeptides
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248248 Isolated human transporters proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/09/2004	US20040248247 Helix-loop-helix (BHLH) motif and a per-rrnt-sim homology domain (pas domain) (BHLH-PAS) protein for use in identifying modulators for diagnosis, prevention and treatment of retardation and nervous system disorders
12/09/2004	US20040248245 Zinc activated ion channel
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248238 Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production
12/09/2004	US20040248236 Bacillus strain and antibiotic screening method
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248231 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders
12/09/2004	US20040248220 Using cadherin expression as diagnostic and prognostic indicator of tumor cell expression and/or progression
12/09/2004	US20040248219 Methods for diagnosing and evaluating cancer
12/09/2004	US20040248218 Gene SCC-112 and diagnostic and therapeutic uses thereof
12/09/2004	US20040248216 Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
12/09/2004	US20040248215 Immunoglobulin fusion comprising human chorionic gonadotropin component for use in treatment and prevention of viral infection and cell proliferative disorders
12/09/2004	US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248202 Labeled chimeric membrane protein for use as tool in identifying modulators for treatment and prevention of viral infection and cell proliferative disorders
12/09/2004	US20040248198 Arf and hdm2 interaction domains and methods of use thereof
12/09/2004	US20040248196 Methods of screening based on the egf receptor crystal structure
12/09/2004	US20040248194 Peptide screen
12/09/2004	US20040248192 Composition
12/09/2004	US20040248187 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides
12/09/2004	US20040248184 Regeneration protein for use in diagnosis, prevention and treatment of diabetes and cardiovascular disorders; antidiabetic agents
12/09/2004	US20040248180 Nucleotide sequences coding modified chromgenic and/or fluorescent protein for use as diagnostic indicators in genetic engineering
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248175 Embryogenic regulatory protein for use in diagnosis, prevention and treatment of cell proliferative and reproductive disorders
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248166 Nucleotide sequences coding peptide receptor for use as tools in diagnosis, prevention and treatment of cancer, arthritis or viral infection
12/09/2004	US20040248160 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
12/09/2004	US20040248156 Nucleotide sequences coding complement pathway protein domains for use in diagnosis and treament of viral infection, inflammation, diabetes, immune and lipid metabolism disorders
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof
12/09/2004	US20040248154 Hormone transcription factor for use in identifying tissue-selective estrogens and controlling heterologous gene expression
12/09/2004	US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design
12/09/2004	US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering
12/09/2004	US20040248139 Eit-6, a polypeptide encoded by an estrogen regulated gene
12/09/2004	US20040248138 Human angiomotin-like protein 1
12/09/2004	US20040248137 Human and mammalian stem cell-derived neuron survival polypeptides
12/09/2004	US20040248133 Method for determining cell cycle position
12/09/2004	US20040248132 Regulatory sequences which control expression from seven in absentia homologue-1(siah-1) and death receptor 5 (DR5) for use in identifying modulators of apoptosis and cell proliferative; antitumor agents
12/09/2004	US20040248129 Neural polypeptide for use as tool in identifying modulators for controlling body weight; treating obesity
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248123 Membrane protein receptor for use in identifying modulator of taste; point mutations; antibodies; food processing and bitterness; phenotype analysis
12/09/2004	US20040248119 Dna fragments containing gene having function relating to autonomous proliferation of plasmid

1 ... 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 ... 2916